Two infants with tuberculid associated with Kawasaki disease

Hiroko Yamada, Haruka Ohta, Shunji Hasegawa, Yoshihiro Azuma, Masanari Hasegawa, Ryo Kadoya, Noriko Ohbuchi, Yuji Ohnishi, Seigo Okada, Madoka Hoshide, Shouichi Ohga

Research output: Contribution to journalArticlepeer-review

8 Citations (Scopus)


Bacille de Calmette et Guerin (BCG) is the only licensed tuberculosis vaccine to prevent severe tuberculosis. The adverse events of BCG vaccination, including local reactions, lymphadenitis, osteomyelitis, tuberculid, and disseminated infection, have been reported. Two infants presented erythema at the inoculation site of BCG after the resolution of Kawasaki disease (KD). They received BCG vaccination 1 week and 6 weeks before the KD onset, respectively. Intravenous immunoglobulin improved the KD activity, however the skin rash of BCG inoculation site extended to the face and extremities days 24 and 10 after the KD onset, respectively. Both bacteriological study and interferon-γ release assay were negative for Mycobacterium tuberculosis infection. These patients were diagnosed as having tuberculid after KD. The skin lesions gradually disappeared without antibiotic therapy over 2 months. The development of tuberculid in these patients might be associated with the remnant immune activation of KD.

Original languageEnglish
Pages (from-to)2772-2776
Number of pages5
JournalHuman Vaccines and Immunotherapeutics
Issue number11
Publication statusPublished - Nov 1 2016
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology
  • Pharmacology


Dive into the research topics of 'Two infants with tuberculid associated with Kawasaki disease'. Together they form a unique fingerprint.

Cite this